No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 3.0900
- -0.0100-0.32%
Close Jun 18 16:00 ET
- 3.1300
- +0.0400+1.29%
Post 17:51 ET
6.05MMarket Cap-140P/E (TTM)
3.2000High3.0617Low17.75KVolume3.1219Open3.1000Pre Close55.87KTurnover0.96%Turnover RatioLossP/E (Static)1.96MShares61.200052wk High0.49P/B5.70MFloat Cap3.030052wk Low--Dividend TTM1.84MShs Float21599978.4000Historical High--Div YieldTTM4.46%Amplitude3.0300Historical Low3.1470Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Tenax Therapeutics | 10-Q: Quarterly report
Express News | Tenax Therapeutics Q1 EPS $(3.12) Misses $(2.40) Estimate
Express News | Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Tenax Therapeutics 1Q Loss/Shr $3.12 >TENX
Tenax Therapeutics 1Q Loss/Shr $3.12 >TENX
Express News | Tenax Therapeutics Announces New US Patent Covering The Use Of Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction, The New Patent Provides Protections Through December 2040
Express News | Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction (Ph-Hfpef)
Comments
$Tenax Therapeutics(TENX.US$ needs major volume
1
$Tenax Therapeutics(TENX.US$ The news about the patent i posted about late yesterday is now hitting all major news outlets! Will it give a PI today?
4
$Tenax Therapeutics(TENX.US$
NEWS
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
NEWS
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
$Tenax Therapeutics(TENX.US$ Benzinga· 1 min ago
Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
2
7
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg